Skip to main content
JW LIFESCIENCE CORPORATION logo

JW LIFESCIENCE CORPORATION — Investor Relations & Filings

Ticker · 234080 ISIN · KR7234080000 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2022-03-29 Declaration of Voting R…
Country KR South Korea
Listing KO 234080

About JW LIFESCIENCE CORPORATION

https://www.jw-lifescience.co.kr/lifesc…

JW LIFESCIENCE CORPORATION is a specialized manufacturer focused on the development and production of infusion solutions. The company's product portfolio includes a comprehensive range of intravenous (IV) fluids, from basic solutions to advanced nutrient infusions containing essential components such as amino acids, lipids, proteins, vitamins, and minerals. A key area of innovation is the development of high-value-added products, including multi-chambered infusion solutions. The company operates world-class manufacturing facilities and maintains dedicated research and development centers to support its commitment to producing high-quality medical fluids for patient treatment.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and director appointments. This aligns perfectly with the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of an outside director. This falls under the category of changes in the company's board of directors or senior management.
2022-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from JW Life Science announcing the submission of its audit report (감사보고서 제출). It provides a summary of the audit opinion (unqualified/적정) and key financial highlights (assets, liabilities, revenue, profit) for the fiscal year ending 2021-12-31. According to the 'Menu vs Meal' rule, this is an announcement of the audit report's submission rather than the full audit report itself, making it a Report Publication Announcement (RPA). FY 2021
2022-03-28 Korean
사업보고서제출기한연장신고서 (2021.12)
Report Publication Announcement Classification · 100% confidence The document is a 'Report of Extension of Filing Deadline for Annual Report' (사업보고서제출기한연장신고서). It is a regulatory filing submitted to the Financial Services Commission and the Korea Exchange, explaining that the company cannot meet the statutory deadline for its annual report due to delays in the external audit process. Since it is a regulatory notification regarding the filing status rather than the annual report itself, and it does not fit into other specific categories like M&A or dividends, it is classified as a Regulatory Filing (RNS).
2022-03-21 Korean
기타경영사항(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from JW Life Science regarding a delay in the submission of their audit report. It is a short, formal announcement (under 5,000 characters) explaining a procedural delay in compliance with the External Audit Act. Since it does not fit into specific categories like 'Audit Report' (which would be the report itself) or 'Annual Report', and serves as a general regulatory disclosure of a corporate event, it is classified as a Regulatory Filing (RNS).
2022-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for JW Life Science. It contains the agenda for the upcoming Annual General Meeting (AGM), including voting items on financial statements, director appointments, and remuneration limits. This document is a standard proxy statement/notice sent to shareholders to inform them of the meeting details and solicit their votes, which falls under the Proxy Solicitation & Information Statement category.
2022-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.